Keywords: medicis, hit, generic, competition, fears, shares, skin

Medicis hit by generic competition fears

Article | 07 December 2000

Print This

Shares in US skin care company Medicis Pharmaceutical fell by nearly15% to $50.25 on December 5, after a generic version of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in